Kane Biotech Announces Amendment to Warrant Terms and Early Exercise Warrant Incentive Program Aug 5, 2009
DispersinB(R) Overproduction Using a Novel Approach Published in the Journal of Industrial Microbiology & Biotechnology Jul 21, 2009
Kane Biotech Receives an Additional Contribution From NRC-IRAP to Develop Its DispersinB(R) Antibiofilm Wound Gel Product Feb 5, 2009
Kane Biotech Has Been Selected as One of Canada's Top 10(TM) Emerging Life Sciences Companies Sep 30, 2008
